Grant: Team Grant: Sepsis Research Network - LOI
University of British Columbia
$25,000.00
SONRIS 2.0: Sepsis Outcomes Network to Improve Survival
FY 2018-19
Summary
Mission Statement: Working together with sepsis survivors, Industry Stakeholders, Clinicians and Scientists, SONRIS 2.0 will strive to halve the number of deaths from sepsis in Canada by 2025.
Canada needs a National Sepsis Network. Serious infection is the leading cause of death and disability worldwide. Sepsis is defined as one or more new organ failure(s) as a result of the primary infection. Once infection has progressed to sepsis, at least 20% of patients succumb in the first 90 days following admission to hospital. There are currently no diagnostics, nor therapies (apart from antimicrobials) available for patients at risk of sepsis.
Built by patients for patients. Patients will be active partners in our sepsis network. Through their engagement we will optimize the relevance of our research and increase the pace and generalizability of knowledge translation. As we reach out to current and future patients partners we will operate by the principles of inclusiveness, support, mutual respect and the aim to co-build a network to improve patient outcomes.
Leading scientists and their science. To achieve meaningful breakthroughs the top scientists in Canada must be engaged. Using objective measures (http://expertscape.com/ex/sepsis/c/ca) our scientists include 4 of the top 10 (Boyd, Russell, Walley, Kumar) sepsis researchers based in Canada. Dr Kumar will lead a program which will centre upon how to contain and kill the infectious organism(s) . Dr Walley will lead a program which will harness the power of our own cholesterol transport system(s) to purify bacterial toxins found in blood. Dr Drucker is renowned for his work leading to development of three new classes of medications for treatment of diabetes and short bowel syndrome who was named Officer of the Order of Canada in 2015. His newest area of research merges Diabetes and sepsis
Department
Program
Team Grant: Sepsis Research Network - LOI
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
400025
Name
Boyd John H
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Team Grant : Sepsis Research Network
Projecttitle
SONRIS 2.0: Sepsis Outcomes Network to Improve Survival
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$25,000
Cihrequipment2
$0
Programname2
Team Grant: Sepsis Research Network - LOI
Keyworddelim
Diabetes; Infectious Disease; Lipoproteins; Nutrition; Sepsis
Abstract
Mission Statement: Working together with sepsis survivors, Industry Stakeholders, Clinicians and Scientists, SONRIS 2.0 will strive to halve the number of deaths from sepsis in Canada by 2025.
Canada needs a National Sepsis Network. Serious infection is the leading cause of death and disability worldwide. Sepsis is defined as one or more new organ failure(s) as a result of the primary infection. Once infection has progressed to sepsis, at least 20% of patients succumb in the first 90 days following admission to hospital. There are currently no diagnostics, nor therapies (apart from antimicrobials) available for patients at risk of sepsis.
Built by patients for patients. Patients will be active partners in our sepsis network. Through their engagement we will optimize the relevance of our research and increase the pace and generalizability of knowledge translation. As we reach out to current and future patients partners we will operate by the principles of inclusiveness, support, mutual respect and the aim to co-build a network to improve patient outcomes.
Leading scientists and their science. To achieve meaningful breakthroughs the top scientists in Canada must be engaged. Using objective measures (http://expertscape.com/ex/sepsis/c/ca) our scientists include 4 of the top 10 (Boyd, Russell, Walley, Kumar) sepsis researchers based in Canada. Dr Kumar will lead a program which will centre upon how to contain and kill the infectious organism(s) . Dr Walley will lead a program which will harness the power of our own cholesterol transport system(s) to purify bacterial toxins found in blood. Dr Drucker is renowned for his work leading to development of three new classes of medications for treatment of diabetes and short bowel syndrome who was named Officer of the Order of Canada in 2015. His newest area of research merges Diabetes and sepsis
Competitiondate
201901
Approvedterm2
1 yr 0 mth
Pinamesdelim
Boyd, John H; Brunham, Liam R; Hux, Janet E; Lovshin, Julie A; Rush, Barret; Russell, James A; Senior, Peter A; Drucker, Daniel J; Kumar, Anand; Walley, Keith R
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Circ &Respiratory Hlth~ $12,500~ $0~Inst of Infection & Immunity~ $12,500~ $0~